Lavie; Arnon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lavie; Arnon.The latest application filed is for "truncated guinea pig l-asparaginase variants and methods of use".

Company Profile

3.5.12

Lavie; Arnon - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
L-asparaginase variants and fusion proteins with reduced L-glutaminase activity and enhanced stability Grant 10,821,160 - Lavie , et al. November 3, 2	2020-11-03
Truncated Guinea Pig L-asparaginase Variants And Methods Of Use App 20200239867 - Lavie; Arnon ; et al.	2020-07-30
L-asparaginase Variants And Fusion Proteins With Reduced L-glutaminase Activity And Enhanced Stability App 20190070274 - LAVIE; Arnon ; et al.	2019-03-07
Deoxycytidine kinase inhibitors Grant 9,981,961 - Radu , et al. May 29, 2	2018-05-29
Deoxycytidine Kinase Inhibitors App 20170204090 - RADU; CAIUS G. ; et al.	2017-07-20
Deoxycytidine Kinase Inhibitors App 20160237076 - Radu; Caius G. ; et al.	2016-08-18
Non-immunogenic Positron Emission Tomography Reporter Gene Systems App 20140248212 - Radu; Caius G. ; et al.	2014-09-04
Use of specifically engineered enzymes to enhance the efficacy of prodrugs Grant 8,349,318 - Lavie , et al. January 8, 2	2013-01-08
Use Of Specifically Engineered Enzymes To Enhance The Efficacy Of Prodrugs App 20110129470 - Lavie; Arnon ; et al.	2011-06-02
Thymidylate Kinase Mutants and Uses Thereof App 20110014165 - Medin; Jeffrey A. ; et al.	2011-01-20
Use of specifically engineered enzymes to enhance the efficacy of prodrugs Grant 7,858,745 - Lavie , et al. December 28, 2	2010-12-28
Thymidylate Kinase Mutants And Uses Thereof App 20090074733 - Medin; Jeffrey A. ; et al.	2009-03-19
Thymidylate Kinase Mutants And Uses Thereof App 20090068158 - Medin; Jeffrey A. ; et al.	2009-03-12
Use of specifically engineered enzymes to enhance the efficacy of prodrugs Grant 7,419,811 - Lavie , et al. September 2, 2	2008-09-02
Use of Specifically Engineered Enzymes to Enhance the Efficacy of Prodrugs App 20070258968 - Lavie; Arnon ; et al.	2007-11-08
Use of specifically engineered enzymes to enhance the efficacy of prodrugs App 20050008648 - Lavie, Arnon ; et al.	2005-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.